Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review)
Authors:
Open Access
- 10 September 2015
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 12 (5) , 6405-6414
Abstract
The hepatitis B virus (HBV) infection is a major risk factor in the development of chronic hepatitis (CH) and hepa-tocellular carcinoma (HCC). The activation-induced cytidine deaminase (AID)/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC) family of cytidine deaminases is significant in innate immunity, as it restricts numerous viruses, including HBV, through hypermutation-dependent and -independent mechanisms. It is important to induce covalently closed circular (ccc)DNA degradation by interferon-α without causing side effects in the infected host cell. Furthermore, organisms possess multiple mechanisms to regulate the expression of AID/APOBECs, control their enzymatic activity and restrict their access to DNA or RNA substrates. Therefore, the AID/APOBECs present promising targets for preventing and treating viral infections. In addition, gene polymorphisms of the AID/APOBEC family may alter host susceptibility to HBV acquisition and CH disease progression. Through G-to-A hypermutation, AID/APOBECs also edit HBV DNA and facilitate the mutation of HBV DNA, which may assist the virus to evolve and potentially escape from the immune responses. The AID/APOBEC family and their associated editing patterns may also exert oncogenic activity. Understanding the effects of cytidine deaminases in CH virus-induced hepatocarcinogenesis may aid with developing efficient prophylactic and therapeutic strategies against HCC.Keywords
This publication has 99 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Medical Virology of Hepatitis B: how it began and where we are nowVirology Journal, 2013
- Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activityBiochemical and Biophysical Research Communications, 2011
- APOBEC3G: a double agent in defenseTrends in Biochemical Sciences, 2011
- Complex regulation and function of activation-induced cytidine deaminaseTrends in Immunology, 2011
- APOBEC3A can activate the DNA damage response and cause cell‐cycle arrestEMBO Reports, 2011
- APOBEC2, a selective inhibitor of TGFβ signaling, regulates left–right axis specification during early embryogenesisDevelopmental Biology, 2011
- The interferon-induced expression of APOBEC3G in human blood–brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous systemVirology, 2007
- Fine-scale structural variation of the human genomeNature Genetics, 2005
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003